Is GKIT or MRK a better dividend investment in 2026?

GKIT currently yields 5555.56% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: GKIT offers higher current income.

What is the dividend yield difference between GKIT and MRK?

GKIT has a forward dividend yield of 5555.56% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 5552.80 percentage points.

Home › Compare › GKIT vs MRK

GKIT vs MRK: Dividend Comparison 2026

GKIT yields 5555.56% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GKIT wins by $173383299298071.94M in total portfolio value

INVESTMENT

TIME HORIZON10 years

GKIT

● Live price

5555.56%

Share price

$0.04

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$173383299298072.00M

Annual income

$167,453,967,894,000,300,000.00

Full GKIT calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — GKIT vs MRK

📍 GKIT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GKIT	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GKIT + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GKIT pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GKIT

Annual income on $10K today (after 15% tax)

$472,222.22/yr

After 10yr DRIP, annual income (after tax)

$142,335,872,709,900,260,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, GKIT beats the other by $142,335,872,709,900,240,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GKIT + MRK for your $10,000?

GKIT: 50%MRK: 50%

100% MRK50/50100% GKIT

Portfolio after 10yr

$86691649649036.03M

Annual income

$83,726,983,947,000,150,000.00/yr

Blended yield

96.58%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GKIT

No analyst data

Altman Z

-3.3

Piotroski

3/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GKIT buys

MRK buys

No recent congressional trades found for GKIT or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGKITMRK

Forward yield	5555.56% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$173383299298072.00M ✓	$56.8K
Annual income after 10y	$167,453,967,894,000,300,000.00 ✓	$9,798.13
Total dividends collected	$172983452329089.31M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: GKIT vs MRK ($10,000, DRIP)

Year	GKIT Portfolio	GKIT Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$566,256	$555,555.56	$11,206	$366.19	+$555.0K → GKIT
2	$30,006,493	$29,400,599.98	$12,650	$502.35	+$29.99M → GKIT
3	$1,488,153,251	$1,456,046,302.99	$14,407	$694.19	+$1488.14M → GKIT
4	$69,079,898,381	$67,487,574,402.39	$16,585	$967.82	+$69079.88M → GKIT
5	$3,001,733,475,908	$2,927,817,984,640.30	$19,342	$1,363.89	+$3001733.46M → GKIT
6	$122,111,548,308,987	$118,899,693,489,765.72	$22,913	$1,947.19	+$122111548.29M → GKIT
7	$4,651,108,281,906,614	$4,520,448,925,215,998.00	$27,662	$2,823.89	+$4651108281.88M → GKIT
8	$165,892,045,974,674,900	$160,915,360,113,034,850.00	$34,159	$4,173.35	+$165892045974.64M → GKIT
9	$5,541,431,218,758,608,000	$5,363,926,729,565,706,000.00	$43,337	$6,308.80	+$5541431218758.56M → GKIT
10	$173,383,299,298,072,000,000	$167,453,967,894,000,300,000.00	$56,776	$9,798.13	+$173383299298071.94M → GKIT

GKIT vs MRK: Complete Analysis 2026

GKIT — Stock

Greenkraft, Inc. manufactures and distributes automotive products for fleet operators, cities, and businesses in the United States. The company offers commercial forward cabin trucks that run on alternative fuels, such as compressed natural gas or liquefied propane gas. It also manufactures and sells alternative fuel systems; and converts petroleum-based fuel vehicles to run on alternative fuels, such as CNG or LPG. The company has strategic partnership with CEE, LLC and G&K Automotive Conversion Inc. for research and development activities, as well as to test its engines prior to applying for the CARB and EPA certifications. Greenkraft, Inc. is headquartered in Santa Ana, California.

Full GKIT Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this GKIT vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GKIT vs SCHD GKIT vs JEPI GKIT vs O GKIT vs KO GKIT vs MAIN GKIT vs JNJ GKIT vs ABBV GKIT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.